PRESS RELEASES
Subscribe to our latest press releases
Aperio Expands Global Digital Pathology Presence with New Subsidiary in Asia
Office in Tokyo Latest Milestone in Global Growth for Digital Pathology Leader
Vista, CA – May 5, 2009 – Aperio, a global leader in digital pathology for the healthcare and life sciences industry, has expanded its international presence with a new subsidiary in Tokyo, Japan to meet growing market demand for the company's digital pathology solutions. The expansion is being led by Reiko Nishiguchi, sales director, to provide sales, technology, service and marketing support throughout Asia via a dedicated multi-lingual staff.
The new office strengthens Aperio's operations in Asia, where the company has been working regionally through a distributor. Japan has emerged as an important strong-hold for the company in the past two years as evidenced by numerous installations of Aperio's complete digital pathology solution which includes the ScanScope® digital slide scanning system, Spectrum™ data management software, and image analysis software. The majority of customers leveraged grant funding provided by Japan's Ministry of Health, Labor, and Welfare to help overcome Japan's pathology-specific challenges. Business growth in China is being driven by a high level of investments by global pharmaceutical companies.
"The momentum for Aperio continues to build world-wide, as organizations turn to us for assistance in ensuring timely, global, and secure access to pathology data without the encumbrance of glass slides," said Dirk Soenksen, CEO of Aperio. "In countries like China, digital pathology is revolutionizing the pharmaceutical and CRO markets because the technology overcomes customs laws that often prohibit or slow down the importation and/or exportation of tissue needed for clinical trials. Because digital pathology data can be accessed via computer, pathologists now have a vastly simpler way to share slides internationally."
Aperio also has several installations throughout Singapore, Taiwan, Korea and Thailand - markets well poised for further growth. Aperio currently has an installed base of more than 500 systems in 31 countries, including more than two-thirds of the top 15 rated U.S. hospitals, leading academic medical centers and reference laboratories, and two-thirds of the top 15 pharmaceutical companies.
About Aperio
Aperio is digitizing pathology. We provide systems and services for digital pathology, which is an environment for the management and interpretation of pathology information that originates with the digitization of a glass slide. Aperio's award-winning ScanScope® slide scanning systems and Spectrum™ digital pathology information management software improve the efficiency and quality of pathology services for pathologists and other professionals. Applications include education, remote viewing, archival and retrieval, basic research and image analysis. Aperio's products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For clearance updates and more information, please visit www.aperio.com.
Media Inquiries:
Myla Wagner
Myla Wagner Public Relations
925.736.7515
myla@mylawagnerpr.com
Product Inquiries:
Kevin Whiteley
Vice President, Marketing
Aperio
760.539.1177
kwhiteley@aperio.com